The strain of the cannabis plant used to make the medicinal cannabis medicine is the specific sub family of the type of plant used.
When heating medical cannabis to appropriate temperatures this releases a vapour from the flower. The vapour contains the active ingredients of the medication, which may include tetrahydrocannabinol (THC), cannabidiol (CBD), other cannabinoids, terpenes, and flavonoids.
Titration is the name given to the process of optimising the most appropriate dose of a medication. When initiating medical cannabis the dose is started low and slowly titrated to find the dose which produces the optimum effect, whilst seeking to minimise side effects.
Tetrahydrocannabinol (THC) is a natural compound found in the cannabis plant. It is one of over 140 cannabinoids identified from cannabis flowers. THC interacts with cannabinoid receptors in the brain and nervous system, particularly with CB1 receptors, which are associated with mood, memory, and coordination. Unlike cannabidiol (CBD), THC is commonly known for its euphoric […]
These are the undesirable effects of a medicine. If you experience any side effects from medical cannabis, report these to us at [email protected]. We report all adverse events through the Yellow Card Scheme. You can report them yourself by logging on to their website: https://yellowcard.mhra.gov.uk/
Shared care refers to a collaborative approach to healthcare delivery in which responsibility for the ongoing management of a patient’s condition is shared between multiple healthcare providers. Shared care allows us to coordinate and communicate between specialist consultants and specialist prescribers where clinically appropriate, resulting in patients receiving care in an integrated and seamless manner.
In the UK, medications are classified under different schedules based on their potential for harm, misuse, and therapeutic value. Schedule 2 medicines, also known as controlled drugs, are substances that have potential for abuse or misuse but are recognised to have legitimate medical uses. These medications are subject to strict regulations regarding their production, prescription, […]
The Curaleaf Access Scheme provides reduced clinical review costs for patients who contribute to Curaleaf’s evidence platform, the UK Medical Cannabis Registry. This allows patients to access the same high quality care, whilst also contributing their anonymous data to growing the evidence base of medical cannabis in the UK.
Also known as PROMS, are questionnaires that have been shown in research studies to be an effective way of tracking changes in the specific indications they were made to monitor.
A patient registry is a systematic collection of standardised information about individuals diagnosed with a particular medical condition or disease. These registries are designed to gather comprehensive data on patients’ demographics, medical history, treatments received, outcomes, and other relevant factors. Curaleaf Clinic has set up the UK Medical Cannabis Registry, the largest real-world dataset on […]
Medical cannabis refers to specific cannabis-based products that are only available on prescription. The products must be manufactured in accordance with regulations set out by regulators to ensure their consistency and they meet pharmaceutical standards. Medical cannabis is dispensed in various forms, including oil administered under the tongue; dried cannabis inhaled with a vaporiser; ointments […]
A group of healthcare professionals who are specialist in a variety of different illnesses or are from different professional backgrounds, who meet to discuss treatment of patients to ensure the best possible outcomes.
